Literature DB >> 312292

Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor.

G Carpenter, L King, S Cohen.   

Abstract

Membranes prepared from A-431 human epidermoid carcinoma cells retained the ability to bind 125I-labeled epidermal growth factor (EGF) in a specific manner. In the presence of [gamma-32P]ATP and Mn2+ or Mg2+, this membrane preparation was capable of phosphorylating endogenous membrane components, including membrane-associated proteins; the major phosphorylated amino acid residue detected in partial acid hydrolysates was phosphothreonine. The binding of EGF to these membranes in vitro resulted in a severalfold stimulation of the phosphorylation reaction; again, the major phosphorylated amino acid residue detected in partial acid hydrolysates was phosphothreonine. Membrane-associated dephosphorylation reactions did not appear to be affected by EGF. The phosphorylation reaction was not stimulated by cyclic AMP or cyclic GMP in the absence or presence of EGF. The phosphorylation system of the membrane was able to utilize [gamma-32P]GTP in both the basal and EGF-stimulated reactions. The enhanced membrane phosphorylation was specific for EGF and its derivatives; a wide variety of other peptide hormones were ineffective. The A-431 membrane preparation also was capable of phosphorylating exogenous proteins, such as histone, phosvitin, and ribonuclease, by a process which was stimulated by EGF. These findings suggest that one of the biochemical consequences of the binding of EGF to membranes is a rapid activation of a cyclic AMP-independent phosphorylating system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312292

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  85 in total

Review 1.  Monoclonal antibodies to epidermal growth factor receptors in studies of receptor structure and function.

Authors:  T Kawamoto; G H Sato; K Takahashi; M Nishi; S Taniguchi; J D Sato
Journal:  Cytotechnology       Date:  1990-05       Impact factor: 2.058

2.  Activity of the epidermal-growth-factor receptor and phospholipase C-gamma 1 in heat-stressed fibroblasts and A-431 cells.

Authors:  S M Liu; G Carpenter
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

Review 3.  Epidermal growth factor receptor: elements of intracellular communication.

Authors:  S M Hernández-Sotomayor; G Carpenter
Journal:  J Membr Biol       Date:  1992-06       Impact factor: 1.843

4.  Epidermal growth factor counteracts the glycogenic effect of insulin in parenchymal hepatocyte cultures.

Authors:  M H Chowdhury; L Agius
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

5.  Temperature-dependent lateral and transverse distribution of the epidermal growth factor receptor in A431 plasma membranes.

Authors:  J R Azevedeo; D A Johnson
Journal:  J Membr Biol       Date:  1990-12       Impact factor: 1.843

6.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

Review 7.  Structure and function of tyrosine kinase receptors.

Authors:  M F White
Journal:  J Bioenerg Biomembr       Date:  1991-02       Impact factor: 2.945

8.  Origins of growth factors: NGF and EGF.

Authors:  Stanley Cohen
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

9.  Epidermal growth factor stimulates rat cardiac adenylate cyclase through a GTP-binding regulatory protein.

Authors:  B G Nair; H M Rashed; T B Patel
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

10.  Biologically active synthetic fragments of epidermal growth factor: localization of a major receptor-binding region.

Authors:  A Komoriya; M Hortsch; C Meyers; M Smith; H Kanety; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.